Pediatric and young adult exposure to chemiluminescent glow sticks

Archives of Pediatrics and Adolescent Medicine

Volumn 156, Issue 9, 2002, Pages 901-904

  Hoffman, Robert J ^a,b,c   Nelson, Lewis S ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b NEW YORK CITY POISON CONTROL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMILUMINESCENT PRODUCT; TOXIC SUBSTANCE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHEMOLUMINESCENCE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; EXPOSURE; EYE; FEMALE; HUMAN; INFANT; INGESTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEWBORN; PRIORITY JOURNAL; SKIN; SYMPTOMATOLOGY;

EID: 0036766698     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.156.9.901     Document Type: Article

References (5)

1. Poisindex System 2000: dibutyl phthalate. In: Rumack BH, Rider PK, Gelman CR, eds. Poisindex System. Englewood, Colo: Micromedex Inc; 2000.
2. Gall H, Khler A, Peter RU. Anaphylactic shock reaction to dibutyl-phthalate-containing capsules. Dermatology. 1999;199:169-170.
3. Occupational Safety & Health Administration. Occupational safety and health guideline for dibutyl phthalate. Washington, DC: Government Printing Office; 1999.
4. Keys N, Erickson T, Lipscomb J. Glow compound exposure [abstract]. J Toxicol Clin Toxicol. 1995;33:488.
5. Stephenson CP, Hunt GE, Topple AN, McGregor IS. The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain. Neuroscience. 1999;92:1011-1023.